New GI Treatment Voquenza Approved For Helicobacter Pylori Infection; Other Indications May Follow - Forbes

In May, FDA approved Voquenza (vonoprazan fumarate), in combination with anti-biotics, for H.pylori infection. In March, Phathom Pharmaceuticals submitted an NDA to FDA for the use of vonoprazan as a treatment for the healing of all grades of erosive reflux e…

Helicobacter pylori illustration. getty Last month, the Food and Drug Administration (FDA) approved Voquenza Dual (vonoprazan fumarate + amoxicillin) and Triple Paks (vonoprazan fumarate + amoxicil… [+3412 chars]

full article...